Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement

Ann Surg Oncol. 2009 Jul;16(7):1751-6. doi: 10.1245/s10434-009-0413-9. Epub 2009 Apr 24.
No abstract available

Publication types

  • Consensus Development Conference
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Chemotherapy, Adjuvant
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Humans
  • Neoadjuvant Therapy
  • Pancreatic Neoplasms / diagnosis
  • Pancreatic Neoplasms / surgery
  • Pancreatic Neoplasms / therapy*
  • Radiotherapy, Adjuvant
  • Research Design

Substances

  • Antineoplastic Agents